Emergent to manufacture Ebola Tx in Md.

Message Topic Search Topic Options Post Reply Create New Topic Printable Version Translate Topic

   Biotech company to manufacture Ebola treatment in
Baltimore [Maryland, USA]

20 Jul 2015

GAITHERSBURG,
Md. — A
biotechnology company has announced that a drug that could cure patients of the
Ebola virus will be manufactured at its Baltimore facility.

The Baltimore Sun
(http://bsun.md/1VlmvMz ) reports that Emergent BioSolutions made the
announcement Monday. The defense department's Biomedical Advanced Research and
Development Authority is paying the Gaithersburg company $19.7 million to make
a treatment for the Ebola virus.

Officials say the treatment is
similar to the drug ZMapp used at the height of the Ebola outbreak last year,
fighting the virus with antibodies developed from tobacco plants.

The agency is comparing other
pharmaceutical companies' Ebola antibodies to Mapp Pharmaceuticals' ZMapp.

It is the second major Ebola-related
treatment to be manufactured at the Emergent facility. Last year, Emergent
produced a booster shot used with a leading Ebola vaccine candidate. 

<http://www.idahostatesman.com/2015/07/20/3903005/biotech-company-to-manufacture.html>

-------------------------------------------------  

Author	Message Topic Search Topic Options Post Reply Create New Topic Printable Version Translate Topic
Ms.Mary.Malone Members Profile Send Private Message Find Members Posts Add to Buddy List Adviser Group Joined: May 18 2015 Location: California, USA Status: Offline Points: 4605	Post Options Post Reply Quote Ms.Mary.Malone Report Post Thanks(0) Quote Reply Topic: Emergent to manufacture Ebola Tx in Md. Posted: July 20 2015 at 4:14pm
	Biotech company to manufacture Ebola treatment in Baltimore [Maryland, USA] 20 Jul 2015 GAITHERSBURG, Md. — A biotechnology company has announced that a drug that could cure patients of the Ebola virus will be manufactured at its Baltimore facility. The Baltimore Sun (http://bsun.md/1VlmvMz ) reports that Emergent BioSolutions made the announcement Monday. The defense department's Biomedical Advanced Research and Development Authority is paying the Gaithersburg company $19.7 million to make a treatment for the Ebola virus. Officials say the treatment is similar to the drug ZMapp used at the height of the Ebola outbreak last year, fighting the virus with antibodies developed from tobacco plants. The agency is comparing other pharmaceutical companies' Ebola antibodies to Mapp Pharmaceuticals' ZMapp. It is the second major Ebola-related treatment to be manufactured at the Emergent facility. Last year, Emergent produced a booster shot used with a leading Ebola vaccine candidate. <http://www.idahostatesman.com/2015/07/20/3903005/biotech-company-to-manufacture.html> -------------------------------------------------
	"We are only seeing the ears of the hippo" --Dr. David Jambai (Head of Sierra Leone's Disease and Prevention Control